Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

被引：69
作者：
Nicholls, AJ [1 ]
机构：
[1] Roche Global Dev, Palo Alto, CA 94304 USA
来源：
CLINICAL BIOCHEMISTRY | 1998年 / 31卷 / 05期
关键词：
D O I：
10.1016/S0009-9120(98)00056-3
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：329 / 333
页数：5
相关论文
共 10 条
[1]  
Bullingham RES, 1996, TRANSPLANT P, V28, P925
[2]  
GRINYO J, 1995, LANCET, V345, P1321
[3]  
*HOFFM ROCH INC, 1995, MYC MOF PRESCR INF
[4]  
Hosmer D., 1989, Applied Logistic Regression, V1st, DOI DOI 10.1097/00019514-200604000-00003
[5]  
Keown P, 1996, TRANSPLANTATION, V61, P1029
[6]   THE RANDOMIZED CONCENTRATION-CONTROLLED TRIAL - AN EVALUATION OF ITS SAMPLE-SIZE EFFICIENCY [J].
SANATHANAN, LP ;
PECK, CC .
CONTROLLED CLINICAL TRIALS, 1991, 12 (06) :780-794
[7]   MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].
SOLLINGER, HW .
TRANSPLANTATION, 1995, 60 (03) :225-232
[8]  
TAKAHASHI K, 1995, TRANSPLANT P, V27, P1421
[9]  
Tsina I, 1996, J CHROMATOGR B, V675, P119
[10]   Time-dependent effects of fixed covariates in Cox regression [J].
Verweij, PJM ;
vanHouwelingen, HC .
BIOMETRICS, 1995, 51 (04) :1550-1556
1